Average Co-Inventor Count = 4.87
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ptc Therapeutics, Inc. (51 from 183 patents)
2. Vertex Pharmaceuticals, Inc. (11 from 1,149 patents)
3. Pct Therapeutics, Inc. (0 patent)
62 patents:
1. 12139499 - Heteroaryl compounds for treating Huntington's disease
2. 12103926 - Compounds for treating huntington's disease
3. 11858941 - Heterocyclic and heteroaryl compounds for treating Huntington's disease
4. 11780839 - Compounds for treating Huntington's disease
5. 11638706 - Methods for treating Huntington's disease
6. 11180483 - Substituted reverse pyrimidine Bmi-1 inhibitors
7. 10959988 - Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
8. 10947231 - Processes for the preparation of substituted tetrahydro beta-carbolines
9. 10881658 - Methods for treating Huntington's disease
10. 10874672 - Methods for treating Huntington's disease
11. 10584115 - Substituted pyridine and pyrazine BMI-1 inhibitors
12. 10428050 - Substituted reverse pyrimidine Bmi-1 inhibitors
13. 10370371 - Substituted pyrimidine Bmi-1 inhibitors
14. 10300047 - Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
15. 10071081 - Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use